Inhibition of HIF-1α Reduced Blood Brain Barrier Damage by Regulating MMP-2 and VEGF During Acute Cerebral Ischemia

about

Inhibition of HIF-1α Reduced Blood Brain Barrier Damage by Regulating MMP-2 and VEGF During Acute Cerebral Ischemia

Item

http://www.wikidata.org/entity/Q58764670

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Inhibition of HIF-1α Reduced B ...... During Acute Cerebral Ischemia

@en

Inhibition of HIF-1α Reduced B ...... During Acute Cerebral Ischemia

@nl

type

Item

label

Inhibition of HIF-1α Reduced B ...... During Acute Cerebral Ischemia

@en

Inhibition of HIF-1α Reduced B ...... During Acute Cerebral Ischemia

@nl

prefLabel

Inhibition of HIF-1α Reduced B ...... During Acute Cerebral Ischemia

@en

Inhibition of HIF-1α Reduced B ...... During Acute Cerebral Ischemia

@nl

P1476

Inhibition of HIF-1α Reduced B ...... During Acute Cerebral Ischemia

@en

P2093

Beiqun Zhou

http://www.w3.org/2001/XMLSchema#string

Congying Xu

http://www.w3.org/2001/XMLSchema#string

Jingxia Gu

http://www.w3.org/2001/XMLSchema#string

Qiaobing Guan

http://www.w3.org/2001/XMLSchema#string

Shuxia Qian

http://www.w3.org/2001/XMLSchema#string

Xiaoling Zhang

http://www.w3.org/2001/XMLSchema#string

Xinchun Jin

http://www.w3.org/2001/XMLSchema#string

Yanping Wang

http://www.w3.org/2001/XMLSchema#string

Yanyun Sun

http://www.w3.org/2001/XMLSchema#string

Yufei Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Astrocyte responses to injury: VEGF simultaneously modulates cell death and proliferation

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Hypoxia-induced neuroinflammatory white-matter injury reduced by minocycline in SHR/SP.

Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain.

Normobaric hyperoxia combined with minocycline provides greater neuroprotection than either alone in transient focal cerebral ischemia.

Hyperglycemia, acute ischemic stroke, and thrombolytic therapy

Pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator.

Differential effects of HIF-1 inhibition by YC-1 on the overall outcome and blood-brain barrier damage in a rat model of ischemic stroke

Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage.

Matrix metalloproteinases and free radicals in cerebral ischemia.

P304

288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNCEL.2018.00288

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30233326

http://www.w3.org/2001/XMLSchema#string

P921

cerebral infarction

blood–brain barrier

P932

6132021

http://www.w3.org/2001/XMLSchema#string